Month: February 2021

The New America High Income Fund, Inc. Announces Election to Opt in to Maryland Control Share Acquisition Act

Written by Customer Service on February 16, 2021. Posted in Mergers And Acquisitions.

BOSTON, Feb. 16, 2021 (GLOBE NEWSWIRE) — The board of directors (the “Board”) of The New America High Income Fund, Inc. (the “Fund”) announced that the Fund has elected to be subject to the Maryland Control Share Acquisition Act (the “MCSAA”), effective immediately.The Board believes that electing to be subject to the MCSAA protects the interests of the Fund. Maryland lawmakers instituted the MCSAA to limit the ability of any single stockholder to exert undue influence in pursuit of short-term gains at the expense of long-term value for Fund stockholders and the Fund’s ability to achieve its investment objective.The election to become subject to the MCSAA limits the ability of holders of “control shares” to vote those shares above various threshold levels that start at 10%, unless the other stockholders of the Fund reinstate those...

CloudMD to Acquire VisionPros, a Rapidly Growing Digital Eyecare Platform with a Robust Suite of Digital Vision Care Tools

Written by Customer Service on February 16, 2021. Posted in Mergers And Acquisitions.

VisionPros is headed by leading minds in the industry – including the pioneer of the first online vision test platform launched in the United StatesVisionPros is a vertically integrated eyecare platform with almost 1 million unique customer accounts in North AmericaUnique subscription model with flexible monthly options; currently 18% of customer base on VisionPros.com subscribed and growingPlanned launch of innovative, best-in-class digital vision test technology embedded into e-commerce platform in 2021Highly scalable business model, synergistic to CloudMD’s technology stack with significant cross-selling opportunitiesIncreases CloudMD’s annual revenue run rate to over $85 millionVANCOUVER, British Columbia, Feb. 16, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company”...

nCino Announces Timing of its Fourth Quarter and Fiscal Year 2021 Results Conference Call

Written by Customer Service on February 16, 2021. Posted in Public Companies.

WILMINGTON, N.C., Feb. 16, 2021 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO) will report financial results for its fourth quarter and fiscal year ended January 31, 2021, after the market close on Wednesday, March 31, 2021. nCino will host a conference call and webcast that day at 4:30 p.m. ET to discuss its financial results.What: nCino’s Fourth Quarter and Fiscal Year 2021 Financial Results Conference CallWhen: Wednesday, March 31, 2021 at 4:30 p.m. ETWebcast Link: https://investor.ncino.com/ Replay: A webcast replay will be available on the Investor Relations section of nCino’s website following the call. About nCinonCino (NASDAQ: NCNO) is the worldwide leader in cloud banking. The nCino Bank Operating System® empowers financial institutions with scalable technology to help them achieve revenue growth, greater efficiency, cost...

BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of North American Sales

Written by Customer Service on February 16, 2021. Posted in Public Companies.

CRESSKILL, N.J. and JERUSALEM, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced the addition of Fran Hackett as Vice President of North American Sales effective February 16, 2021.“As a veteran sales leader with a robust background across varied medical markets, Fran’s addition will be critical to this phase of the Company’s growth,” said Hadar Levy, Senior Vice President and General Manager of BrainsWay. “He has been instrumental in building industry-leading teams, and I am excited to have him take over our commercial efforts in North America.”“BrainsWay has great momentum in establishing Deep TMS as the leading, non-pharmacological treatment for a range of debilitating brain...

Evaxion Biotech Opens New Office and Laboratories to Support Future Growth

Written by Customer Service on February 16, 2021. Posted in Public Companies.

COPENHAGEN, Denmark, Feb. 16, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (Nasdaq: EVAX), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today the opening of its new corporate headquarters and research laboratory facility located in the DTU Science Park in Hoersholm near Copenhagen, Denmark.The new facility will unite Evaxion’s diverse research and corporate operations – currently located across Denmark and Italy – at a single site. The new laboratories are designed and built specifically for Evaxion.Lars Wegner, CEO of Evaxion, said: “The opening of our new site will support Evaxion’s aim of becoming a world leader in AI-Immunology, by bringing our workforce together at a site with fully equipped...

Monopar宣布其评估Validive®预防化疗引起口咽癌（OPC）患者重度口腔粘膜炎（SOM）效果的2b/3期（VOICE）试验完成首次患者给药

Written by Customer Service on February 16, 2021. Posted in Public Companies.

伊利诺伊州威尔梅特, Feb. 16, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc.（纳斯达克股票代码：MNPR）是一家临床阶段生物制药公司，专注于开发延长癌症患者寿命或提高其生活质量的专利疗法。该公司今天宣布，已在Validive®的2b/3期VOICE（prevention of chemoradiotherapy-induced severe oral mucositis in patients with oropharyngeal cancer，预防口咽癌症患者因化疗引起严重口腔黏膜炎）试验中完成了首次患者给药。Validive的粘膜粘附颊片制剂可延长和增强药物向粘膜辐射损伤区域的局部递送，易于在上唇下方使用，可让患者每天一次在家自行服用。“美国每年约4万患者尚无有效选择来预防或治疗放化疗引起SOM的OPC。我们很高兴能实现此次这一重要里程碑，让我们距离将Validive带给这些患者更近了一步。”Monopar首席执行官、医学博士Chandler Robinson表示。“SOM是放化疗（CRT）的一种痛苦且使人衰弱的严重不良反应，不管是短期还是长期，都可能对临床结局以及生活质量产生重大负面影响。”“新诊断出的口咽癌患者的数量正在增长。”Monopar首席科学官Andrew Mazar博士表示， “CRT是OPC的标准治疗方法，但遗憾的是，接受CRT的OPC患者中有60-70％会在治疗过程中发生严重的口腔粘膜炎。”已完成的Validate 2期试验表明，在接受CRT治疗的OPC患者中，与安慰剂相比，每天一次服用100µg Validive片剂可使SOM发生率降低40%。这项当前的多中心、随机、双盲、安慰剂对照和适应性设计的2b/3期VOICE临床试验最多将招募大约260名患者。有关Validive的2b/3期VOICE试验的更多信息，请访问 www.ClinicalTrials.gov，研究编号为：NCT...

FTI Consulting Appoints Bryan Zumwalt as Head of Government Affairs Practice

Written by Customer Service on February 16, 2021. Posted in Public Companies.

WASHINGTON, Feb. 16, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that Bryan Zumwalt has been named a Senior Managing Director and Head of Government Affairs within the Strategic Communications segment. Mr. Zumwalt will advise clients as they navigate today’s increasingly complex regulatory and political landscape to achieve successful corporate and legislative outcomes. He will be based in Washington, D.C. and report to Brian Kennedy, the Americas Head of Strategic Communications.“Having counseled senior lawmakers and senior corporate executives in previous career roles, Bryan’s unique experience and deep sector expertise make him a valuable addition to our firm,” said Mr. Kennedy. “His business acumen, proven leadership skills and record of successfully navigating legislative and regulatory challenges...

Monopar Announces First Patient Dosed in its Phase 2b/3 VOICE Trial Evaluating Validive® for the Prevention of Chemoradiotherapy-Induced Severe Oral Mucositis (SOM) in Oropharyngeal Cancer (OPC)

Written by Customer Service on February 16, 2021. Posted in Public Companies.

WILMETTE, Ill., Feb. 16, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced it has dosed the first patient in its Phase 2b/3 VOICE trial of Validive® for the prevention of chemoradiotherapy-induced severe oral mucositis in patients with oropharyngeal cancer (VOICE).Validive’s mucoadhesive buccal tablet formulation allows for prolonged and enhanced local delivery of drug to the regions of mucosal radiation damage, and its easy application under the upper lip allows for convenient once-daily self-administration in the patient’s home setting.“With this important milestone accomplished we are excited to be one step closer to bringing...

DraftKings Names Jennifer Aguiar as Chief Compliance Officer

Written by Customer Service on February 16, 2021. Posted in Public Companies.

BOSTON, Feb. 16, 2021 (GLOBE NEWSWIRE) — DraftKings Names Jennifer Aguiar as Chief Compliance OfficerDraftKings Inc. (Nasdaq: DKNG) today announced that Jennifer Aguiar, CRP, CRCM, CAMS, CIPP/US, has been named the company’s Chief Compliance Officer, an executive level position that reports directly to Jason Robins, DraftKings’ co-founder, CEO and Chairman. Previously, Aguiar served as the company’s Vice President, Compliance and Risk, reporting into Tim Dent. Dent, who joined DraftKings in 2013, most recently served as the Chief Compliance Officer in addition to numerous other leadership positions related to compliance, finance, legal and regulatory matters. He will be moving into the position of Senior Vice President, Regulatory Operations, and will continue to manage the company’s relationships with regulatory authorities before...

Aya Gold & Silver Intercepts 1,946 g/t Ag over 9m at Zgounder, Extending Strike East

Written by Customer Service on February 16, 2021. Posted in Public Companies.

Mont-Royal, Feb. 16, 2021 (GLOBE NEWSWIRE) — Montreal, Quebec, February 16, 2021 – Aya Gold & Silver Inc. (TSX: AYA) (“Aya” or the “Corporation”) is pleased to announce additional high-grade silver results from its 2020 diamond drill hole (“DDH”) exploration program at the Zgounder Silver Mine in the Kingdom of Morocco. Results from 12 DDH continue to intersect high-grade silver mineralisation along strike to the east and at depth below the current resource.Key HighlightsZG-20-30 intersected 1,946 grams per tonne (“g/t”) Ag over 9.0mZG-20-31 intersected 688 g/t Ag over 17.5mZG-SF-20-15 intersected 1,505 g/t Ag over 6mSurface results demonstrate high-grade silver extension to the east Underground results extend high-grade silver mineralisation at depthDrilling is underway to extend the strike to the west The 12 DDH results...

Month: February 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals